PIK3CA and glioblastoma: Furthermore, in a novel PI3K-PTEN induced brain cancer mouse model, the deletion of CREB reduces malignancy and increases survival [22], suggesting that dual inhibition of PI3K signaling and CREB transactivation may be an effective treatment for GBM and other malignant brain cancers with aberrant PI3K signaling.